已收盘 05-15 16:00:00 美东时间
0.000
0.00%
LeonaBio, Inc. has expanded its Board of Directors with the addition of Fred Callori, Natalie Holles, and Peter B. Silverman, effective May 5, 2026, while John Fluke Jr. retired on May 4, 2026. The new members bring extensive experience in oncology and neurology drug development, corporate strategy, operational execution, and capital markets. Their expertise aligns with LeonaBio's focus on advancing its clinical pipeline for diseases with high un...
05-07 13:20
Allakos ( ($ALLK) ) has provided an announcement. On May 15, 2025, Allakos Inc....
2025-05-15 21:49
Allakos Inc ALLK.OQ ALLK.O is expected to show no change in quarterly revenue when it reports results on May 7 (estimated) for the period ending March 31 2025 LSEG's mean analyst estimate for Allakos...
2025-05-05 19:58
NEW YORK, April 4, 2025 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...
2025-04-05 00:42
Gainers Allakos (NASDAQ:ALLK) stock rose 48.2% to $0.32 during Wednesday's reg...
2025-04-03 01:06
Eikon search string for individual stock moves: STXBZ The Day Ahead newsletter: https://refini.tv/3LI4BU7 The Morning News Call newsletter: https://refini.tv/3dKUyB8 Wall Street's main indexes fell on...
2025-04-03 00:33
** Shares of drug developer Allakos ALLK.O rise 45.6% to 32 cents premarket ** Concentra Biosciences will buy Allakos for 33 cents per share in cash, a premium of 52% to ALLK's last close ** Allakos s...
2025-04-02 21:21
Allakos ( ($ALLK) ) has shared an update. On April 1, 2025, Allakos Inc. entere...
2025-04-02 20:49
April 2 (Reuters) - Allakos Inc ALLK.O: ALLAKOS INC. ENTERS INTO AGREEMENT TO BE ACQUIRED BY CONCENTRA BIOSCIENCES, LLC FOR $0.33 IN CASH PER SHARE Source text: ID:nGNX5QBzdp Further company coverage:...
2025-04-02 20:04
Allakos ( ($ALLK) ) has released its Q4 earnings. Here is a breakdown of the in...
2025-03-14 12:14